NCT06452316 - Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

May 31, 2026

Conditions

Limbal Stem Cell Deficiency

Interventions

BIOLOGICAL

CSB-001 Ophthalmic Solution 0.1%

CSB-001: human recombinant dHGF (5-amino acid deleted hepatocyte growth factor)

Trial Locations (6)

RECRUITING

Francis Price Jr, MD, Indianapolis

RECRUITING

Midwest Cornea Associates, LLC, Carmel

RECRUITING

Minnesota Eye Consultants, Minnetonka

RECRUITING

Stuart A. Terry, MD PA, San Antonio

RECRUITING

Loma Linda University Eye Institute, Loma Linda

RECRUITING

Legacy Devers Eye Institute, Portland